Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetic with retinopathy

Acta Endocrinologica

Volumn 120, Issue 2, 1989, Pages 187-194

  Hyer, S L ^a   Sharp, P S ^a   Brooks, R A ^a   Burrin, J M ^a   Kohner, E M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; OCTREOTIDE; SOMATOMEDIN;

CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; CIRCADIAN RHYTHM; DIABETIC RETINOPATHY; FEMALE; GROWTH HORMONE; HUMAN; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGE; OCTREOTIDE; SOMATOMEDINS; SUPPORT, NON-U.S. GOV'T;

EID: 0024509355     PISSN: 00015598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)